Tarrik Zaid, MD
Gynecologic Oncology · Sugar Land, TXNPI 1487834883
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,789 of the $2,690 with a category attached, or 66.5%. It is spread thinly across 20 manufacturers, the largest accounting for just 22.5%. That places this record below the midpoint for gynecologic oncology clinicians in TX, where the typical reported total is $3,034.
Across 43 payments — averaging $62.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$606
- Stryker$451
- Baxter Healthcare$289
- Sirtex Medical Inc$189
- Dilon Technologies, Inc.$174
- Davol Inc.$162
- plus $819 from 14 others
Across 33 payments — averaging $4517.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$114K
- Daiichi Sankyo Inc.$36K
What the payments were for
- Consulting fees$45017%
- Travel & lodging$45117%
- Food & beverage$1,78967%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 8 | $606 |
| Stryker | 1 | $451 |
| Baxter Healthcare | 2 | $289 |
| Sirtex Medical Inc | 1 | $189 |
| Dilon Technologies, Inc. | 1 | $174 |
| Davol Inc. | 1 | $162 |
| AstraZeneca | 2 | $139 |
| Merck | 4 | $131 |
| Genmab U.S., Inc. | 5 | $105 |
| Tempus AI, Inc | 4 | $102 |
| Eisai Inc. | 3 | $68 |
| Immunogen, Inc. | 2 | $50 |
| Johnson & Johnson(2 entities) | 2 | $45 |
| AbbVie | 1 | $32 |
| Aroa Biosurgery Incorporated | 1 | $29 |
| Novartis | 1 | $26 |
| Foundation Medicine, Inc. | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $24 |
| Medical Device Business Services, Inc. | 1 | $24 |
| Meditrina | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPY-PHI SYSTEM$451
- ZEJULA$450
- PerClot$289
- SIR-Spheres Microspheres$189
- HemoBlast Bellows$174
- ARISTA AH FLEXITIP$162
- LYNPARZA$112
How this compares
$2,690 in reported general payments places this provider in the 45th percentile of 135 gynecologic oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Letrozole | 70 | $1,667 |
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 28 | $1,061 |
| Megestrol Acetate | 16 | $588 |
| Celecoxib | 13 | $562 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $200 |
| Diclofenac Sodium | 16 | $94 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Sugar Land
- Robert ColemanHouston$864K
- Reagan StreetFort Worth$280K
- Joseph de la GarzaSan Antonio$234K
- Maurie MarkmanHouston$204K
- Dustin MandersDallas$171K
- Tiffany RedfernFort Worth$165K
- Antonio Santillan-GomezSan Antonio$162K
- Michael FrumovitzHouston$156K
- Eugene ToyEl Paso$138K
- Aparna KamatHouston$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.